Medical Xpress November 12, 2024
Center for Genomic Regulation

Researchers at the Center for Genomic Regulation (CRG) reveal that metabolic enzymes known for their roles in energy production and nucleotide synthesis are taking on unexpected “second jobs” within the nucleus, orchestrating critical functions like cell division and DNA repair.

The discovery, reported in two separate research papers in Nature Communications, not only challenges longstanding biological paradigms in cellular biology but also opens new avenues for therapies, particularly against aggressive tumors like triple-negative breast cancer (TNBC).

For decades, biology textbooks have neatly compartmentalized cellular functions. Mitochondria are the powerhouses of the cell, the cytoplasm is a bustling factory floor for , and the nucleus a custodian of genetic information. However, Dr. Sara Sdelci and her team at the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
At JPM, Eli Lilly’s CEO Explains Why Mounjaro, Zepbound Sales Were Lower Than Expected
NIH's unfinished business
Lilly blames slower-than-expected growth for 2024 sales miss
AbbVie to write off $3.5B over failed schizophrenia drug

Share This Article